Hope this hasn't been posted before...Looks interesting.
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
http://investor.myriad.com/releasedetail.cfm?RELEASEid=448383&
SALT LAKE CITY, Mar 2, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced the launch of PROLARIS(TM), a 46-gene prognostic test which quantitatively determines the risk of recurrence in patients who have undergone prostatectomy surgery. For the first time, physicians now have a direct molecular measure of a prostate tumor's capacity to divide and grow by examining the mechanics of growth at the molecular level. PROLARIS is the Company's eighth molecular diagnostic product and the first of two that are planned to be launched this year. -con't-